Awarded

1 - L1_ADALIMUMAB (DOE) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES, EXCLUYENDO LOS NUEVOS TRATAMIENTOS

Track this recordFree account — get alerted when a contract here runs out.
Contract value
€3,630,646
Bids received
1
Published
22 Apr 2026
Awarded
21 Apr 2026
Contract start
21 Apr 2026
Contract end
22 Apr 2027estimated

More awards from this buyer